| RS1573087364 |
CFH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemolytic uremic syndrome, atypical |
| RS1573094617 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1573094789 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1573096202 |
BCL11A
|
Health Risk |
Pathogenic |
— |
| RS1573098889 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1573100371 |
DYSF
|
Health Risk |
Pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1573109761 |
BCL11A
|
Health Risk |
Pathogenic/Likely pathogenic |
Dias-Logan syndrome, Neurodevelopmental delay |
| RS1573118105 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1573120705 |
SPAST
|
Health Risk |
Likely pathogenic |
— |
| RS1573121594 |
SPAST
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1573121790 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1573127804 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiovascular phenotype |
| RS1573138313 |
DYSF
|
Health Risk |
Likely pathogenic |
Distal lower limb muscle weakness, Miyoshi muscular dystrophy 1 |
| RS1573138336 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1573139443 |
SPAST
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1573139616 |
SPAST
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia |
| RS1573139642 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1573142475 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1573142616 |
SPAST
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1573142681 |
SPAST
|
Health Risk |
Likely pathogenic |
— |
| RS1573156283 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia |
| RS1573156341 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1573156433 |
SPAST
|
Health Risk |
Likely pathogenic |
— |
| RS1573157000 |
SPAST
|
Health Risk |
Pathogenic |
— |
| RS1573157108 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1573167562 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1573174147 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Melanoma |
| RS1573174859 |
TPO
|
Health Risk |
Likely pathogenic |
— |
| RS1573176526 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1573186691 |
SPAST
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia |
| RS1573214163 |
CALM2
|
Health Risk |
Pathogenic |
Long QT syndrome 15, Long QT syndrome 1 |
| RS1573214371 |
CALM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome 1, Long QT syndrome 15 |
| RS1573223126 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1573250294 |
POMC
|
Health Risk |
Pathogenic |
Obesity due to pro-opiomelanocortin deficiency, Obesity due to pro-opiomelanocortin deficiency |
| RS1573254045 |
POMC
|
Health Risk |
Pathogenic |
Obesity due to pro-opiomelanocortin deficiency, Obesity due to pro-opiomelanocortin deficiency |
| RS1573261820 |
ZAP70
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe combined immunodeficiency disease, Combined immunodeficiency due to ZAP70 deficiency |
| RS1573262398 |
ZAP70
|
Health Risk |
Pathogenic |
Combined immunodeficiency, Combined immunodeficiency |
| RS1573274915 |
CYP1B1
|
Health Risk |
Likely pathogenic |
Glaucoma 3A, Glaucoma 3A |
| RS1573276416 |
CYP1B1
|
Health Risk |
Likely pathogenic |
Anterior segment dysgenesis 6, Anterior segment dysgenesis 6 |
| RS1573291900 |
DNMT3A
|
Health Risk |
Likely pathogenic |
— |
| RS1573297136 |
DNMT3A
|
Health Risk |
Likely pathogenic |
Tatton-Brown-Rahman overgrowth syndrome, Tatton-Brown-Rahman overgrowth syndrome |
| RS1573300872 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1573313314 |
DNMT3A
|
Health Risk |
Pathogenic |
— |
| RS1573319752 |
POU3F3
|
Health Risk |
Pathogenic/Likely pathogenic |
Snijders blok-fisher syndrome, Snijders blok-fisher syndrome |
| RS1573320043 |
POU3F3
|
Health Risk |
Pathogenic |
Snijders blok-fisher syndrome, Snijders blok-fisher syndrome |
| RS1573320413 |
POU3F3
|
Health Risk |
Pathogenic |
Snijders blok-fisher syndrome, Snijders blok-fisher syndrome |
| RS1573320988 |
POU3F3
|
Health Risk |
Pathogenic/Likely pathogenic |
Snijders blok-fisher syndrome, Snijders blok-fisher syndrome |
| RS1573321115 |
POU3F3
|
Health Risk |
Likely pathogenic |
Snijders blok-fisher syndrome, Inborn genetic diseases |
| RS1573328713 |
HNRNPU
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Developmental and epileptic encephalopathy |
| RS1573330458 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS1573330502 |
HNRNPU
|
Health Risk |
Likely pathogenic |
— |
| RS1573337552 |
HNRNPU
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 54 |
| RS1573337948 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS1573338529 |
HNRNPU
|
Health Risk |
Likely pathogenic |
— |
| RS1573338559 |
DNMT3A
|
Health Risk |
Likely pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS1573340335 |
DNMT3A
|
Health Risk |
Likely pathogenic |
Heyn-Sproul-Jackson syndrome, Heyn-Sproul-Jackson syndrome |
| RS1573340475 |
DNMT3A
|
Health Risk |
Pathogenic |
Heyn-Sproul-Jackson syndrome, Heyn-Sproul-Jackson syndrome |
| RS1573369925 |
SUCLG1
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 9, Mitochondrial DNA depletion syndrome 9 |
| RS1573369929 |
SUCLG1
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 9, Mitochondrial DNA depletion syndrome 9 |
| RS1573374828 |
SUCLG1
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 9, Mitochondrial DNA depletion syndrome 9 |
| RS1573380429 |
TPO
|
Health Risk |
Pathogenic |
Deficiency of iodide peroxidase, Deficiency of iodide peroxidase |
| RS1573396982 |
EIF2AK3
|
Health Risk |
Pathogenic |
— |
| RS1573399606 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS1573422612 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1573422744 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1573423213 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1573423412 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1573424223 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS1573424393 |
NRXN1
|
Health Risk |
Likely pathogenic |
— |
| RS1573436092 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1573436369 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome, Lynch syndrome |
| RS1573436408 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1573436418 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1573436461 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1573436801 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1573436948 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS1573437064 |
MSH2
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Lynch syndrome 1 |
| RS1573437173 |
MSH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms |
| RS1573440435 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1573440792 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1573440880 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1573441348 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lynch syndrome 1, Lynch syndrome 1 |
| RS1573441776 |
MSH2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1573441851 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1573442039 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS1573442055 |
PROC
|
Health Risk |
Likely pathogenic |
Thromboembolism, Thromboembolism |
| RS1573442100 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1573444020 |
PROC
|
Health Risk |
Likely pathogenic |
Reduced protein C activity, Reduced protein C activity |
| RS1573446496 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1573446614 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS1573446832 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1573451078 |
MSH2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1573451108 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1573451339 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS1573451595 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1573451658 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1573451662 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS1573454278 |
ANAPC1
|
Health Risk |
Pathogenic |
Rothmund-Thomson syndrome type 1, Rothmund-Thomson syndrome type 1 |
| RS1573456437 |
MSH2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1573456772 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms |